Sheth KN, Albers GW, Saver JL, Campbell BCV, et al. Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Neurol 2024;23:1205-1213.
PMID: 39577921